Amgen Reports First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Amgen (AMGN) PT Lowered to $183 at RBC Capital
April 25, 2018 7:41 AM EDTRBC Capital lowered its price target on Amgen (NASDAQ: AMGN) to $183.00 (from $189.00) while maintaining a Sector Perform rating.
Analyst Kennen MacKay said AMGN's surprise Q1:18 top and bottom line beats are tempered by legacy base business products largely driving the revenue beat.
... MoreAmgen (AMGN) Tops Q1 EPS by 23c; Boosts Outlook
April 24, 2018 4:02 PM EDTAmgen (NASDAQ: AMGN) reported Q1 EPS of $3.47, $0.23 better than the analyst estimate of $3.24. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.43 billion.
2018 EPS guidance revised to $11.30-$12.28 on a GAAP basis and $12.80-$13.70 on a non-GAAP basis (*** consensus is $13.48); total revenues guidance revised to $21.9-$22.8 billion (*** consensus is $22.61 billion).
"Amgen's strong first-quarter performance was driven by our new and recently launched products, all of which delivered double-digit, volume-driven growth," said Robert A. Bradway, chairman and chief executive officer. "We look... More
